Literature DB >> 14688110

Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia.

Ombeline Rossier1, Shawn R Starkenburg, Nicholas P Cianciotto.   

Abstract

Legionella pneumophila, the gram-negative agent of Legionnaires' disease, possesses type IV pili and a type II protein secretion (Lsp) system, both of which are dependent upon the PilD prepilin peptidase. By analyzing multiple pilD mutants and various types of Lsp mutants as well as performing trans-complementation of these mutants, we have confirmed that PilD and type II secretion genes are required for L. pneumophila infection of both amoebae and human macrophages. Based upon a complete analysis of lspDE, lspF, and lspG mutants, we found that the type II system controls the secretion of protease, RNase, lipase, phospholipase A, phospholipase C, lysophospholipase A, and tartrate-sensitive and tartrate-resistant acid phosphatase activities and influences the appearance of colonies. Examination of the developing L. pneumophila genome database indicated that the organism has two other loci (lspC and lspLM) that are predicted to promote secretion and thus a set of genes that is comparable to the type II secretion genes in other gram-negative bacteria. In contrast to lsp mutants, L. pneumophila pilus mutants lacking either the PilQ secretin, the PspA pseudopilin, or pilin were not defective for colonial growth, secreted activities, or intracellular replication. L. pneumophila dot/icm mutants were also not impaired for type II-dependent exoenzymes. Upon intratracheal inoculation into A/J mice, lspDE, lspF, and pilD mutants, but not pilus mutants, exhibited a reduced ability to grow in the lung, as measured by competition assays. The lspF mutant was also defective in an in vivo kinetic assay. Examination of infected mouse sera revealed that type II secreted proteins are expressed in vivo. Thus, the L. pneumophila Lsp system is a virulence factor and the only type II secretion system linked to intracellular infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688110      PMCID: PMC344012          DOI: 10.1128/IAI.72.1.310-321.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  97 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  In vivo production of a tissue-destructive protease by Legionella pneumophila in the lungs of experimentally infected guinea-pigs.

Authors:  J W Conlan; A Williams; L A Ashworth
Journal:  J Gen Microbiol       Date:  1988-01

Review 3.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  Legionella pneumophila serogroup 14 isolated from patients with fatal pneumonia.

Authors:  R F Benson; W L Thacker; H W Wilkinson; R J Fallon; D J Brenner
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

5.  Thirteenth serogroup of Legionella pneumophila isolated from patients with pneumonia.

Authors:  D S Lindquist; G Nygaard; W L Thacker; R F Benson; D J Brenner; H W Wilkinson
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

6.  The Legionella pneumophila major secretory protein, a protease, is not required for intracellular growth or cell killing.

Authors:  L Szeto; H A Shuman
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

7.  Second serogroup of Legionella feeleii strains isolated from humans.

Authors:  W L Thacker; H W Wilkinson; B B Plikaytis; A G Steigerwalt; W R Mayberry; C W Moss; D J Brenner
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

8.  Genetic, immunological, and cytotoxic comparisons of Legionella proteolytic activities.

Authors:  F D Quinn; M G Keen; L S Tompkins
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

9.  Multiple roles of the pilus biogenesis protein pilD: involvement of pilD in excretion of enzymes from Pseudomonas aeruginosa.

Authors:  M S Strom; D Nunn; S Lory
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.476

10.  Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Authors:  D A Herrington; R H Hall; G Losonsky; J J Mekalanos; R K Taylor; M M Levine
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  80 in total

1.  The major facilitator superfamily-type protein LbtC promotes the utilization of the legiobactin siderophore by Legionella pneumophila.

Authors:  Christa H Chatfield; Brendan J Mulhern; V K Viswanathan; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2011-12-08       Impact factor: 2.777

2.  Legionella pneumophila LbtU acts as a novel, TonB-independent receptor for the legiobactin siderophore.

Authors:  Christa H Chatfield; Brendan J Mulhern; Denise M Burnside; Nicholas P Cianciotto
Journal:  J Bacteriol       Date:  2011-01-28       Impact factor: 3.490

Review 3.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Legionella cardiaca sp. nov., isolated from a case of native valve endocarditis in a human heart.

Authors:  Meghan M Pearce; Nicole Theodoropoulos; Mark J Mandel; Ellen Brown; Kurt D Reed; Nicholas P Cianciotto
Journal:  Int J Syst Evol Microbiol       Date:  2012-01-27       Impact factor: 2.747

5.  The Legionella pneumophila tatB gene facilitates secretion of phospholipase C, growth under iron-limiting conditions, and intracellular infection.

Authors:  Ombeline Rossier; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  The global regulatory proteins LetA and RpoS control phospholipase A, lysophospholipase A, acyltransferase, and other hydrolytic activities of Legionella pneumophila JR32.

Authors:  Markus Broich; Kerstin Rydzewski; Tamara L McNealy; Reinhard Marre; Antje Flieger
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

7.  Rapid escape of the dot/icm mutants of Legionella pneumophila into the cytosol of mammalian and protozoan cells.

Authors:  Maëlle Molmeret; Marina Santic'; Rexford Asare; Reynold A Carabeo; Yousef Abu Kwaik
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

8.  Virulence factors encoded by Legionella longbeachae identified on the basis of the genome sequence analysis of clinical isolate D-4968.

Authors:  Natalia A Kozak; Meghan Buss; Claressa E Lucas; Michael Frace; Dhwani Govil; Tatiana Travis; Melissa Olsen-Rasmussen; Robert F Benson; Barry S Fields
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

9.  The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Authors:  Philipp Aurass; Maren Schlegel; Omar Metwally; Clare R Harding; Gunnar N Schroeder; Gad Frankel; Antje Flieger
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Multiple Legionella pneumophila Type II secretion substrates, including a novel protein, contribute to differential infection of the amoebae Acanthamoeba castellanii, Hartmannella vermiformis, and Naegleria lovaniensis.

Authors:  Jessica Y Tyson; Meghan M Pearce; Paloma Vargas; Sreya Bagchi; Brendan J Mulhern; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.